Journal of Medical Cases, ISSN 1923-4155 print, 1923-4163 online, Open Access
Article copyright, the authors; Journal compilation copyright, J Med Cases and Elmer Press Inc
Journal website https://jmc.elmerpub.com

Case Report

Volume 16, Number 7, July 2025, pages 239-247


Investigation and Management of a Small Outbreak of Septic Knee Arthritis Following Knee Arthroscopy by Stenotrophomonas maltophilia

Figures

↓  Figure 1. The joint fluid of two infected patients through knee arthrocentesis. (a) Case 1. (b): Case 2.
Figure 1.
↓  Figure 2. Arthroscopic presentation of knee septic arthritis of Stenotrophomonas maltophilia. (a) Infrapatellar fat pad and medial part of intercondylar notch. (b) Suprapatellar bursa. (c) Lateral compartment. (d) Medial compartment. ACL: anterior cruciate ligament; LFC: lateral femoral condyle; LM: lateral meniscus; MFC: medial femoral condyle; MM: medial meniscus.
Figure 2.
↓  Figure 3. The appearance of the contaminated arthroscope. (a) Gross look. (b) Object glasses: white arrowhead indicates slight deformation at the junction of glasses and scope body; black arrowhead indicates slight deformation and an enlarged gap at the junction. (c) Port for light cable. (d) Camera glasses.
Figure 3.

Tables

↓  Table 1. Infection Control Investigation of Instruments Associated With Arthroscopy
 
Instrument type Items Sterilization Samples per item Sample positions Positive samples Positive positions
One to four samples per item were collected depending on instrument size, shape, and complexity. Initial test results were presented in the table. Two subsequent rounds of testing were performed, showing negative results. ACL: anterior cruciate ligament; HPGP: hydrogen peroxide gas plasma.
Arthroscope 4 HPGP 3 Surface, object glasses, light cable port 1 Object glasses
Shaver handpiece 3 HPGP 4 Body surface, body cavity, cable surface, plug 0 N/A
Light cable 3 HPGP 3 Cable surface, arthroscope port, light source port 0 N/A
Arthroscope cannula 4 Steam autoclave 2 Surface, cavity 0 N/A
Cannula obturator 4 Steam autoclave 1 Surface 0 N/A
Probe 3 Steam autoclave 1 Surface 0 N/A
Basket forceps 12 Steam autoclave 1 Surface 0 N/A
Grasping forceps 6 Steam autoclave 1 Surface 0 N/A
Microfracture pick 6 Steam autoclave 1 Surface 0 N/A
Arthroscopic curette 3 Steam autoclave 1 Surface 0 N/A
Suture hook 6 Steam autoclave 1 Surface 0 N/A
Suture cutter 3 Steam autoclave 1 Surface 0 N/A
Knot pusher 3 Steam autoclave 1 Surface 0 N/A
ACL femoral aimer 2 Steam autoclave 1 Surface 0 N/A
ACL tibial guide 2 Steam autoclave 1 Surface 0 N/A
ACL reamer 12 Steam autoclave 1 Surface 0 N/A
Tendon harvester 2 Steam autoclave 1 Surface 0 N/A
Graft sizer 10 Steam autoclave 1 Surface 0 N/A
Ruler 6 Steam autoclave 1 Surface 0 N/A
General surgical instruments (e.g., scalpel handle, scissor, forceps) 56 Steam autoclave 1 Surface 0 N/A

 

↓  Table 2. Retrospective Survey of Usage of the Contaminated Arthroscope Since “Patient Zero”
 
Operation type Patients Infected patients (positive microbiology) Infected patients (negative microbiology) Infection ratio
ACLR: anterior cruciate ligament reconstruction.
Partial meniscectomy 4 1 2 75%
Meniscus repair 3 2 0 66.7%
ACLR 8 1 0 12.5%
Synovectomy 2 0 1 50.0%
Elbow release 1 0 0 0.0%
Iliotibial band release 1 0 0 0.0%
Total 19 4 3 36.8%

 

↓  Table 3. Summary of the Antibiotic Protocols for Cases 1-4
 
Operation date Case 1 Case 2 Case 3 Case 4
Day -17* Day 4 Day 2 Day 5
The date of case 1’s postoperative outpatient revisit when septic knee arthritis was suspected, was defined as day 0. *Day -17 indicates 17 days before day 0. SMZ-TMP: sulfamethoxazole-trimethoprim.
Protocol Cefepime-sulbactam (3.0 g/8 h) Ceftriaxone (2 g/24 h)
SMZ-TMP (0.96 g/12 h)
Ceftriaxone (2.0 g/24 h) Levofloxacin (0.75 g/d)
SMZ-TMP (1.44 g/8 h)
  Start date Day 1 Day 9 Day 6 Day 12
  End date Day 6 Day 10 Day 8 Day 22
Protocol Levofloxacin (0.5 g/day)
SMZ-TMP (0.96 g/8 h)
Levofloxacin (0.75 g/day)
SMZ-TMP (1.44 g/8 h)
Levofloxacin (0.75 g/day)
SMZ-TMP (1.44 g/8 h)
SMZ-TMP (1.44 g/8 h)
Minocycline (100 mg/12 h)
  Start date Day 7 Day 11 Day 9 Day 23
  End date Day 11 Day 17 Day 22 Day 50
Protocol Levofloxacin (0.75 g/day)
SMZ-TMP (1.44 g/8 h)
Minocycline (100 mg/12 h)
SMZ-TMP (1.44 g/8 h)
Minocycline (100 mg/12 h)
SMZ-TMP (1.44 g/8 h)
Minocycline (100 mg/12 h)
  Start date Day 12 Day 18 Day 23
  End date Day 67 Day 46 Day 50